Performance of the ESC 0/2h-algorithm using high-sensitivity cardiac troponin I in the early diagnosis of myocardial infarction.


Journal

American heart journal
ISSN: 1097-6744
Titre abrégé: Am Heart J
Pays: United States
ID NLM: 0370465

Informations de publication

Date de publication:
12 2021
Historique:
received: 27 02 2021
accepted: 10 08 2021
pubmed: 12 9 2021
medline: 29 12 2021
entrez: 11 9 2021
Statut: ppublish

Résumé

The 2020 guidelines of the European Society of Cardiology (ESC) recommend a novel ESC 0/2h-algorithm as the preferred alternative to the ESC 0/1h-algorithm in the early triage for rule-out and/or rule-in of Non-ST-segment-elevation myocardial infarction (NSTEMI). The aim was to prospectively validate the performance of the ESC 0/2h-algorithm using the high-sensitivity cardiac troponin I (hs-cTnI) assay (ARCHITECT) in an international, multicenter diagnostic study enrolling patients presenting with acute chest discomfort to the emergency department.

Identifiants

pubmed: 34508692
pii: S0002-8703(21)00206-4
doi: 10.1016/j.ahj.2021.08.008
pii:
doi:

Substances chimiques

Biomarkers 0
Troponin I 0

Banques de données

ClinicalTrials.gov
['NCT00470587']

Types de publication

Letter Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-137

Investigateurs

Tobias Zimmermann (T)
Tobias Reichlin (T)
Michael Christ (M)
Christian Puelacher (C)
Jeanne du Fay de Lavallaz (JDF)
Eliska Potlukova (E)
Matthias Diebold (M)
Damian Kawecki (D)
Nicolas Geigy (N)
Katharina Rentsch (K)
Sandra Mitrovic (S)
Carolina Fuenzalida (C)
Noemi Glarner (N)
Beata Morawiec (B)
Piotr Munzk (P)
Tobias Breidthardt (T)
Michael Freese (M)
Beatriz López (B)
Sofia Calderón (S)
Esther Rodriguez Adrada (ER)
Eva Ganovská (E)
Jiri Parenica (J)
Arnold von Eckardstein (A)
Isabel Campodarve (I)
Joaquim Gea (J)

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Luca Koechlin (L)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Cardiac Surgery, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network.

Jasper Boeddinghaus (J)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network.

Thomas Nestelberger (T)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network; Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Pedro Lopez-Ayala (P)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network.

Desiree Wussler (D)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network; Division of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Samyut Shrestha (S)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network; Division of Internal Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Tobias Resa (T)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network.

Karin Wildi (K)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network; Critical Care Research Group, the Prince Charles Hospital, Brisbane, Australia; University of Queensland, Brisbane, Australia.

Adam Bakula (A)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Simon Frey (S)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Òscar Miró (Ò)

GREAT network; Emergency Department, Hospital Clinic, Barcelona, Catalonia, Spain.

F Javier Martin-Sanchez (FJ)

GREAT network; Hospital Clínico San Carlos, Madrid, Spain.

Ivo Strebel (I)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network.

Danielle M Gualandro (DM)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network.

Friedrich S Eckstein (FS)

Department of Cardiac Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.

Oliver Reuthebuch (O)

Department of Cardiac Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.

Dagmar I Keller (DI)

Emergency Department, University Hospital Zurich, Zurich, Switzerland.

Raphael Twerenbold (R)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network.

Maria Rubini Giménez (MR)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network; Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Germany.

Christian Mueller (C)

Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; GREAT network. Electronic address: christian.mueller@usb.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH